Lificiguat
CAS No. 170632-47-0
Lificiguat ( YC1; YC 1; YC-1; Lificiguat )
产品货号. M18115 CAS No. 170632-47-0
YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥348 | 有现货 |
|
10MG | ¥494 | 有现货 |
|
25MG | ¥1029 | 有现货 |
|
50MG | ¥2041 | 有现货 |
|
100MG | ¥3499 | 有现货 |
|
200MG | ¥5176 | 有现货 |
|
500MG | ¥7995 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lificiguat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
-
产品描述Lificiguat, also known as YC-1, is a inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha). YC-1 is widely used as a potent inhibitor of HIF-1alpha both in vitro and in vivo, and is also being developed as a novel anticancer drug. YC-1 effectively inhibits tumor invasion and metastasis, and imply that YC-1 is worth while to further develop as a multipurpose anticancer drug.
-
同义词YC1; YC 1; YC-1; Lificiguat
-
通路Others
-
靶点Other Targets
-
受体sGC;HIF-1α
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number170632-47-0
-
分子量304.34
-
分子式C19H16N2O2
-
纯度98%
-
溶解度DMSO : ≥ 51 mg/mL; 167.58 mM
-
SMILESOCC1=CC=C(C2=NN(CC3=CC=CC=C3)C4=C2C=CC=C4)O1
-
化学全称5-[1-(phenylmethyl)-1H-indazol-3-yl]-2-furanmethanol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Martin E,etal.YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12938-42.
产品手册
关联产品
-
6alpha-Chloro-5beta-...
6alpha-Chloro-5beta-hydroxywithaferin A is a natural product.
-
Microgrewiapine A
Microgrewiapine A is a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes.
-
Congo Red
Congo Red is an azo dye. It binding been used as a diagnostic test for the presence of amyloid in tissue sections.